Conference item icon

Conference item

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD

Subtitle:
Conference abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM; Target Discovery Institute
Oxford college:
St Edmund Hall
ORCID:
0000-0002-4288-5973
Kerstjens, HAM More by this author
Criner, GJ More by this author
Expand authors...
GlaxoSmithKline More from this funder
Publisher:
European Respiratory Society Publisher's website
Volume:
50
Issue:
S61
Pages:
Article: PA1366
Publication date:
2017-12-06
DOI:
EISSN:
1399-3003
ISSN:
0903-1936
Pubs id:
pubs:871822
URN:
uri:750cc2ef-96e1-4181-a42d-1c608f033cd6
UUID:
uuid:750cc2ef-96e1-4181-a42d-1c608f033cd6
Local pid:
pubs:871822

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP